News
-
-
-
-
-
PRESS RELEASE
Communiqué de presse : Dupixent de Sanofi et Regeneron approuvé dans l'UE comme premier médicament ciblé contre l'urticaire chronique spontanée chez les jeunes enfants
Dupixent de Sanofi et Regeneron approuvé pour l'urticaire chronique spontanée (UCS) chez les jeunes enfants par l'UE. Nouvelle approbation élargit l'indication du médicament pour les enfants dès 2 ans -
PRESS RELEASE
Press Release: Sanofi and Regeneron’s Dupixent approved in the EU as the first targeted medicine to treat young children with chronic spontaneous urticaria
Sanofi and Regeneron's Dupixent approved in the EU for young children with chronic spontaneous urticaria, expanding treatment options to address type 2 inflammation -
-
PRESS RELEASE
CGTN AMERICA & CCTV UN: UN Chinese Language Day Celebration with "Chinese Language Shining Civilizations" Event
CGTN America & CCTV UN to host 'Chinese Language Shining Civilizations' event at UN headquarters in New York City for UN Chinese Language Day celebration, highlighting cultural heritage and global significance of Mandarin Chinese -
-